Counselors in Mayodan, NC Accepting Medicare
1 Counselors found. Showing 1 - 1
 Kathryn Coble Thompson, LPCA Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 6845 Nc Highway 135, Mayodan, NC 27027 Phone: 336-623-9711 Fax: 336-635-6864 |
News Archive
Telomerase enzyme structure provides significant new target for anti-cancer therapies
Inappropriate activation of a single enzyme, telomerase, is associated with the uncontrollable proliferation of cells seen in as many as 90 percent of all of human cancers. Since the mid-1990s, when telomerase was first identified in human tumors, scientists have eyed the enzyme as an ideal target for developing broadly effective anti-cancer drugs.
Opinions: Canada's role in global health; Drug licensing agreements promote drug access; Funding for USAID, state; Haiti
After outlining the work of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Michel Kazatchkine, the organization's executive director, highlights the role Canada can play in determining "whether the world can overcome AIDS, tuberculosis and malaria" in a Toronto Star opinion piece, noting the upcoming G8 and G20 summits, as well as the Millennium Development Goal meeting later this year.
Researchers describe germ line functions of par-5 gene
Certain proteins, such as 14-3-3, conserve their basic functions of cell cycle control in diverse organisms, from worms to humans. In a study led by Juli-n Cer-n and Sim- Schwartz Jr, researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Research Institute of Vall d'Hebron (VHIR) respectively, have described germ line functions of par-5, which is one of the two 14-3-3 proteins existing in Caenorhabditis elegans, worms used as experimental model in genetic studies.
Xience V sales out-performing Promus in Japanese drug-eluting stent market: MRG
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, when Abbott Vascular's Xience V and Boston Scientific's Promus entered the Japanese drug-eluting stent market in Q1 2010, both companies picked up share from competitors Medtronic and Cordis.
› Verified 1 days ago